======= SLC29A2 ======= == Gene Information == * **Official Symbol**: SLC29A2 * **Official Name**: solute carrier family 29 member 2 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=3177|3177]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q14542|Q14542]] * **Interactions**: [[https://thebiogrid.org/search.php?search=SLC29A2&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20SLC29A2|Open PubMed]] * **OMIM**: [[https://omim.org/entry/602110|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Mediates equilibrative transport of purine, pyrimidine nucleosides and the purine base hypoxanthine. Very less sensitive than SLC29A1 to inhibition by nitrobenzylthioinosine (NBMPR), dipyridamole, dilazep and draflazine. {ECO:0000269|PubMed:9396714}. |Nucleoside tran| |hypoxanthine transport| |thymine transport| |guanine transport| |uridine transport| |pyrimidine nucleoside transport| |adenine transport| |pyrimidine nucleobase transport| |purine nucleobase transport| |nucleoside transport| |nucleoside transmembrane transport| |nucleoside transmembrane transporter activity| |nucleobase transport| |neurotransmitter reuptake| |neurotransmitter uptake| |carbohydrate derivative transport| |presynapse| |neurotransmitter transport| |basolateral plasma membrane| |nuclear membrane| |nucleobase-containing compound transport| |regulation of neurotransmitter levels| |import into cell| |nucleolus| |transmembrane transport| |integral component of plasma membrane| |establishment of localization in cell| |nitrogen compound transport| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp140|Nicotinate 1000μM R03 exp140]]|-2.15| |[[:results:exp285|GW501516 25μM R06 exp285]]|-1.94| |[[:results:exp292|Menadione 5μM R06 exp292]]|-1.94| |[[:results:exp288|HMS-I2 10μM R06 exp288]]|-1.88| |[[:results:exp103|Taxol 0.004μM R03 exp103]]|-1.74| |[[:results:exp107|UMK57 0.6μM R03 exp107]]|-1.74| |[[:results:exp264|Arsenate 40μM R06 exp264]]|-1.71| |[[:results:exp438|NN-Diethyl-meta-toluamide 500μM R08 exp438]]|1.72| |[[:results:exp470|Chloroquine 32μM R08 exp470]]|1.74| |[[:results:exp530|Thioridazine 5μM R08 exp530]]|1.79| |[[:results:exp50|Nicotinamide 2000μM R01 exp50]]|1.87| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 10357 * **Expression level (log2 read counts)**: 4.45 {{:chemogenomics:nalm6 dist.png?nolink |}}